SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008238
Filing Date
2022-05-09
Accepted
2022-05-09 07:33:18
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20220331.htm   iXBRL 10-Q 2697416
2 EX-10.1 beam-ex10_1.htm EX-10.1 21892
3 EX-31.1 beam-ex31_1.htm EX-31.1 21713
4 EX-31.2 beam-ex31_2.htm EX-31.2 21869
5 EX-32.1 beam-ex32_1.htm EX-32.1 12570
6 EX-32.2 beam-ex32_2.htm EX-32.2 12599
  Complete submission text file 0000950170-22-008238.txt   11449891

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20220331_def.xml EX-101.DEF 306702
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT beam-20220331_cal.xml EX-101.CAL 65029
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20220331_pre.xml EX-101.PRE 480254
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20220331.xsd EX-101.SCH 74851
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20220331_lab.xml EX-101.LAB 552359
81 EXTRACTED XBRL INSTANCE DOCUMENT beam-20220331_htm.xml XML 2475864
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 22903255
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences